LEARNING OBJECTIVES

Title

Educational Objectives (By the end of this session, the learner will be able to…)

Updates in HIV Medicine: Therapeutics Review
Brad Hare, MD

• Describe the latest developments in antiretroviral therapy for both initial and treatment-experienced patients
• Identify optimal candidates for injectable antiretroviral (ARV) therapy
   

WPATH 8 Update
Holly Kim, MD

• Describe the major changes to the WPATH SOC version 8 and the impact on care delivery for transgender and gender diverse people
   

STI Update 2023

• Updates in CDC Guidelines – What’s New for STIs
• Antibiotic Resistance in the Roaring ‘20’s: Updated CDC guidelines for STI Management

Ina Park, MD
 

• Describe and apply the latest CDC recommendations for screening and treatment of STIs
• Apply strategies for prevention of antibiotic resistant STDs
• Identify Peds/Adolescent STIs early and discuss emancipation for treatment confidentially

Liver Disease: Evaluation of Patient with Liver Disorder
Amandeep Sahota, MD

• Evaluate labs and imaging related to the clinical management of liver disease
• Apply evolving practices in the clinical management of liver disease
   

HIV: Innovative Programs at KP
Mona Gahunia, DO, Charulata Ramaprasad, MD & Amanda Thornton, MD

• Utilize new telehealth technologies (e.g., E-Visits) for sexually related issues and HIV care
• Describe lessons learned from how KP responded to pandemic
   

All: Preventative Care – Vaccines, Etc.
Peter Kadlecik, MD & Robert Catalla, MD

• Use strategies to mitigate how COVID-19 affects STI screening and STI prevention
• Describe which vaccines to prescribe and when for adult populations, especially those that prevent STI and virally transmitted malignancies
   

LGBTQ+ Health: Methamphetamine and Other Party Drugs
TBD

• Use strategies to ensure successful referral of patients with substance abuse to care
• Recognize how patients present with substance abuse, including how to identify acute overdose
   

Updates in Liver Disease
Norah Terrault, MD

• Review practical developments in natural history, diagnostics and therapeutics for non-alcohol fatty liver disease, alcohol-associated liver disease and viral liver diseases
   

Diverse Sexual Practices
April Soto, MD

• Describe the diversity of sexual practices commonly seen in adult primary care
• Apply strategies to talk about diverse sexual practices comfortably with patients
   

Anal Cancer Screening and Treatment
Joel Palefsky, MD

• Describe ANCHOR trial updates and impact on guidelines
• Describe anal cancer screening and treatment options
• Consider practical considerations for developing anal cancer screening programs
   

Liver Disease: Hepatitis B, Hepatitis C & Hepatitis D
Varun Saxena, MD

• Utilize screening recommendations for Hepatitis B, C, and D
• Identify at-risk communities which may have higher rates of infection
   

HIV and COVID-19
Jacek Skarbinski, MD

• Describe the effect of COVID-19 on patients living with HIV (e.g., markers/surrogates for severity such as CD4
   

General: Research Update (not limited to HIV)
Michael Silverberg, PhD & Michael Horberg, MD

• Describe key contributions of Kaiser Permanente to the HIV field
• Identify strategies and mechanisms to support ongoing inter regional research
   

LGBTQ+ Health: Intro to Gender Affirming Health Care for Adults
Colin Fields, MD

• Recognize the diversity of gender expression and utilize appropriate terminology
• Describe the process for initiating and monitoring gender affirming hormone therapy in adults
• Describe physical and psychological changes expected with gender medical transition
• Identify the various gender affirming surgical interventions available to TG/GD individuals
   

Monkeypox
TBD

• Identify cases of Monkeypox from history and physical exam and laboratory
• Describe how to treat and advise patients with active cases of Monkeypox
• Describe how to prevent Monkeypox, including vaccination
   

Alcohol Associated Liver Disease
Varun Saxena, MD

• Describe the changes in prevalence and demographics of alcohol associated liver disease and particularly alcohol associated hepatitis
• Review updates in management of alcohol associated liver disease including alcohol associated hepatitis and reduced sobriety pathway to liver transplant listing
   

Liver Disease: Liver Transplant
Paul Chang, MD

• Identify patients with HIV who should be referred for liver transplantation
• Describe outcomes of liver transplantation among patients with HIV
• Apply management strategies to reduce complications post-transplant
   

HIV: HIV & Primary Care: Intro Track
Jennifer Chang, MD

• Screen and diagnose HIV infection
• Perform initial evaluation and management of HIV infection
• Apply narrative medicine and other techniques for a successful patient interview
• Use strategies to maintain medication adherence and engage with patients
   

General: Health Needs of Women Who Have Sex with Women
Jennifer Slovis, MD

• Navigate patient desires for intimacy while keeping safe from COVID
• Discuss safer sex with their patients during the COVID epidemic
• Describe the unique health needs of women who have sex with women, including preventive health
   

LGBTQ+ Health: Gender Diverse Children & Adolescents: Supporting Emotional and Physical Beginnings
Gina Sucato, MD & Hayden McIntyre, MSW

• Describe the unique needs of gender diverse children and adolescents
• Employ strategies to support the care of gender diverse children and adolescents with KP
   

PrEP Updates and Challenges
Michael Horberg, MD

• Describe the latest developments in HIV prevention, including injectables
• Employ appropriate monitoring for patients on PrEP and recognize when to discontinue
   

Clinical Controversies- A Case Based Format
Panel: Jacek Skarbinksi, MD, Amandeep Sahota, MD, Holly Kim, MD
Moderators: William Towner, MD & Molly Stenzel, MD

• Implement changes to clinical practice to improve quality performance
• Implement the latest HIV STI, and liver disease treatment paradigms in care
• Describe the unique health issues of a transgender patient and provide appropriate care to this patient population
   

TARGET AUDIENCE

All physicians, clinical pharmacists, advance practice providers, scientists, and other providers of care and research for patients with HIV, Liver Disease, sexually transmitted infections (STI), or LGBTQ+ Health.
 

ACCREDITATION & CREDIT DESIGNATION STATEMENTS

The Kaiser Permanente National CME Program is accredited by the Accreditation Council for Continuing Medical Education ( ACCME) to provide continuing medical education for physicians.

The Kaiser Permanente National CME Program designates this Live activity for a maximum of 11 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Day 1: 6.75 AMA PRA Category 1 Credit(s)™.
Day 2: 4.25 AMA PRA Category 1 Credit(s)™.
Total: 11 AMA PRA Category 1 Credit(s)™.

Continuing education for our nonphysician colleagues: This educational activity has been designated for 11 AMA PRA Category 1 Credit(s)™ by the Kaiser Permanente National CME Program, an ACCME accredited provider. Nurses and Physician Assistants (PAs) may report up to 11 hours toward the continuing education requirements for license renewal. ‘CME’ can be written in lieu of the provider number on all licensure renewal applications. Other health care providers should check with their licensing agency for credit reciprocity.

Persons with Disabilities
In compliance with the Americans with Disabilities Act, all reasonable efforts will be made to accommodate persons with disabilities at the meeting. If you have any special dietary or accommodation needs, please notify the meeting planner listed, prior to the symposium in the Department of Physician Education at (626) 405-3928 or tie-line 8-335-3928. This advance notice will help us serve you better.